Effects of a Paleolithic Diet on Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- PMID: 31041449
- PMCID: PMC6628854
- DOI: 10.1093/advances/nmz007
Effects of a Paleolithic Diet on Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Erratum in
-
Effects of a Paleolithic Diet on Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Adv Nutr. 2020 Jul 1;11(4):1054. doi: 10.1093/advances/nmaa033. Adv Nutr. 2020. PMID: 32666106 Free PMC article. No abstract available.
Expression of concern in
-
Editorial Expression of Concern.Adv Nutr. 2020 Jan 1;11(1):181. doi: 10.1093/advances/nmz119. Adv Nutr. 2020. PMID: 31841124 Free PMC article. No abstract available.
Abstract
There is some evidence supporting the beneficial effects of a Paleolithic Diet (PD) on cardiovascular disease risk factors. This diet advises consuming lean meat, fish, vegetables, fruits, and nuts and avoiding intake of grains, dairy products, processed foods, and added sugar and salt. This study was performed to assess the effects of a PD on cardiovascular disease risk factors including anthropometric indexes, lipid profile, blood pressure, and inflammatory markers using data from randomized controlled trials. A comprehensive search was performed in the PubMed, Scopus, ISI Web of Science, and Google Scholar databases up to August, 2018. A meta-analysis was performed using a random-effects model to estimate the pooled effect size. Meta-analysis of 8 eligible studies revealed that a PD significantly reduced body weight [weighted mean difference (WMD) = -2.17 kg; 95% CI: -3.48, -0.87 kg], waist circumference (WMD = -2.90 cm; 95% CI: -4.51, -1.28 cm), body mass index (in kg/m2) (WMD = -1.15; 95% CI: -1.68, -0.62), body fat percentage (WMD = -1.38%; 95% CI: -2.08%, -0.67%), systolic (WMD = -4.24 mm Hg; 95% CI: -7.11, -1.38 mm Hg) and diastolic (WMD = -2.95 mm Hg; 95% CI: -4.72, -1.18 mm Hg) blood pressure, and circulating concentrations of total cholesterol (WMD = -0.22 mg/dL; 95% CI: -0.42, -0.03 mg/dL), TGs (WMD = -0.23 mg/dL; 95% CI: -0.46, -0.01 mg/dL), LDL cholesterol (WMD = -0.13 mg/dL; 95% CI: -0.25, -0.01 mg/dL), and C-reactive protein (CRP) (WMD = -0.41 mg/L; 95% CI: -0.81, -0.008 mg/L) and also significantly increased HDL cholesterol (WMD = 0.05 mg/dL; 95% CI: 0.005, 0.10 mg/dL). However, sensitivity analysis revealed that the overall effects of a PD on lipid profile, blood pressure, and circulating CRP concentrations were significantly influenced by removing some studies, hence the results must be interpreted with caution. Although the present meta-analysis revealed that a PD has favorable effects on cardiovascular disease risk factors, the evidence is not conclusive and more well-designed trials are still needed.
Keywords: C-reactive protein; Paleolithic diet; Paleolithic nutrition; anthropometric indexes; blood pressure; lipid profile; meta-analysis.
Copyright © American Society for Nutrition 2019.
Figures
Comment in
-
Errors in Meta-Analysis Should Be Corrected: Comment on "Effects of a Paleolithic Diet on Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials".Adv Nutr. 2020 Jul 1;11(4):1047-1048. doi: 10.1093/advances/nmaa035. Adv Nutr. 2020. PMID: 32348451 Free PMC article. No abstract available.
-
Reply to X Chen et al.Adv Nutr. 2020 Jul 1;11(4):1048-1050. doi: 10.1093/advances/nmaa036. Adv Nutr. 2020. PMID: 32348461 Free PMC article. No abstract available.
References
-
- Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng Z-J, Flegal K, O'Donnell C, Kittner S et al. .. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113(6):e85. - PubMed
-
- WHO. Global atlas of CV prevention and control. [Internet] Geneva: World Health Organization; 2011; [accessed 20 July, 2018]. Fact sheet no. 317. Available from: https://www.who.int/cardiovascular_diseases/about_cvd/en/.
-
- Perk J, De Backer G, Gohlke H, Graham I, Reiner Ž, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R et al. .. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Int J Behav Med. 2012;19(4):403–88. - PubMed
-
- Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Greenland P, Grundy SM et al. .. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation. 2002;106(3):388–91. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
